Doxorubicin-Induced Cardiometabolic Disturbances: What Can We Do?

Doxorubicin-Induced Cardiometabolic Disturbances: What Can We Do? Publisher

Avagimyan A^{1, 2} ; Pogosova N^{3, 4} ; Rizzo M⁵ ; Sarrafzadegan N²

Show Affiliations

1. Yerevan State Medical University after M. Heratsi, Yerevan, Armenia
2. Isfahan Cardiovascular Research Centre, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
3. Sciences and Preventive Cardiology, National Medical Research Centre of Cardiology after Acad. E. I. Chazov, Moscow, Russian Federation
4. Evidence-Based Medicine Department, Institute of Medicine, Patrice Lumumba Peoples' Friendship University of Russia (RUDN), Moscow, Russian Federation
5. Cardiometabolic Medicine Department, University of Palermo, Palermo, Italy

Source: Frontiers in Clinical Diabetes and Healthcare Published:2025

[No abstract available]

Experts (# of related papers)

Style	Citing Format
MLA	Avagimyan A, et al.. "Doxorubicin-Induced Cardiometabolic Disturbances: What Can We Do?." Frontiers in Clinical Diabetes and Healthcare, vol. 6, no. , 2025, pp. -.
APA	Avagimyan A, Pogosova N, Rizzo M, Sarrafzadegan N (2025). Doxorubicin-Induced Cardiometabolic Disturbances: What Can We Do?. Frontiers in Clinical Diabetes and Healthcare, 6(), -.
Chicago	Avagimyan A, Pogosova N, Rizzo M, Sarrafzadegan N. "Doxorubicin-Induced Cardiometabolic Disturbances: What Can We Do?." Frontiers in Clinical Diabetes and Healthcare 6, no. (2025): -.
Harvard	Avagimyan A et al. (2025) 'Doxorubicin-Induced Cardiometabolic Disturbances: What Can We Do?', Frontiers in Clinical Diabetes and Healthcare, 6(), pp. -.
Vancouver	Avagimyan A, Pogosova N, Rizzo M, Sarrafzadegan N. Doxorubicin-Induced Cardiometabolic Disturbances: What Can We Do?. Frontiers in Clinical Diabetes and Healthcare. 2025;6():-.
BibTex	@article{ author = {Avagimyan A and Pogosova N and Rizzo M and Sarrafzadegan N}, title = {Doxorubicin-Induced Cardiometabolic Disturbances: What Can We Do?}, journal = {Frontiers in Clinical Diabetes and Healthcare}, volume = {6}, number = {}, pages = {-}, year = {2025} }
RIS	TY - JOUR AU - Avagimyan A AU - Pogosova N AU - Rizzo M AU - Sarrafzadegan N TI - Doxorubicin-Induced Cardiometabolic Disturbances: What Can We Do? JO - Frontiers in Clinical Diabetes and Healthcare VL - 6 IS - SP - EP - PY - 2025 ER -